These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23206208)

  • 21. Aetiological factors for oral manifestations of HIV.
    Palmer GD; Robinson PG; Challacombe SJ; Birnbaum W; Croser D; Erridge PL; Hodgson T; Lewis D; McLaren A; Zakrzewska JM
    Oral Dis; 1996 Sep; 2(3):193-7. PubMed ID: 9081758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia.
    Kolokotronis A; Kioses V; Antoniades D; Mandraveli K; Doutsos I; Papanayotou P
    Oral Surg Oral Med Oral Pathol; 1994 Jul; 78(1):41-6. PubMed ID: 8078662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of oral manifestations with CD4 count in HIV-infected patients.
    Sontakke SA; Umarji HR; Karjodkar F
    Indian J Dent Res; 2011; 22(5):732. PubMed ID: 22406727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of cutaneous and oral diseases in HIV-infected men.
    Mirowski GW; Hilton JF; Greenspan D; Canchola AJ; MacPhail LA; Maurer T; Berger TG; Greenspan JS
    Oral Dis; 1998 Mar; 4(1):16-21. PubMed ID: 9655039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of HIV-related oral lesions in adults.
    Petruzzi MN; Cherubini K; Salum FG; Figueiredo MA
    Rev Saude Publica; 2013 Feb; 47(1):52-9. PubMed ID: 23703130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.
    Lifson AR; Hilton JF; Westenhouse JL; Canchola AJ; Samuel MC; Katz MH; Buchbinder SP; Hessol NA; Osmond DH; Shiboski S
    AIDS; 1994 Jan; 8(1):73-9. PubMed ID: 8011239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of periodontal attachment in HIV-seropositive military personnel.
    Tomar SL; Swango PA; Kleinman DV; Burt BA
    J Periodontol; 1995 Jun; 66(6):421-8. PubMed ID: 7562330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
    J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease.
    Greenspan JS
    Oral Dis; 1997 May; 3 Suppl 1():S13-7. PubMed ID: 9456650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is erythematous candidiasis associated with advanced HIV disease?
    Robinson PG; Challacombe SJ; Sheiham A; Zakrzewska JM
    Oral Dis; 1997 May; 3 Suppl 1():S116-8. PubMed ID: 9456670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of HIV transmission associated with risk of oral lesions in HIV-infected subjects in Thailand.
    Nittayananta W; Chanowanna N; Winn T
    J Oral Pathol Med; 2010 Feb; 39(2):195-200. PubMed ID: 20002981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-related oral manifestations among adolescents in a multicenter cohort study.
    Shiboski CH; Wilson CM; Greenspan D; Hilton J; Greenspan JS; Moscicki AB;
    J Adolesc Health; 2001 Sep; 29(3 Suppl):109-14. PubMed ID: 11530311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of oral lesions and their predictive value for progression of HIV disease.
    Begg MD; Lamster IB; Panageas KS; Mitchell-Lewis D; Phelan JA; Grbic JT
    Oral Dis; 1997 Sep; 3(3):176-83. PubMed ID: 9467362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral lesions in Brazilian HIV-infected children undergoing HAART.
    Miziara ID; Filho BC; Weber R
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with specific clinical forms of oral candidiasis in HIV-infected Brazilian adults.
    Gonçalves LS; Júnior AS; Ferreira SM; Sousa CO; Fontes TV; Vettore MV; Torres SR
    Arch Oral Biol; 2013 Jun; 58(6):657-63. PubMed ID: 23123068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.
    Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T
    Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs.
    Hilton JF; Donegan E; Katz MH; Canchola AJ; Fusaro RE; Greenspan D; Greenspan JS
    Am J Epidemiol; 1997 Jan; 145(2):164-74. PubMed ID: 9006313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital.
    Nanteza M; Tusiime JB; Kalyango J; Kasangaki A
    BMC Oral Health; 2014 Nov; 14():143. PubMed ID: 25432363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal study of the prevalence and prognostic implications of oral manifestations in romanian children infected with human immunodeficiency virus type 1.
    Vaseliu N; Carter AB; Kline NE; Kozinetz C; Cron SG; Matusa R; Kline MW
    Pediatr Infect Dis J; 2005 Dec; 24(12):1067-71. PubMed ID: 16371867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.